G‐CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis
Open Access
- 29 March 2006
- journal article
- fj express
- Published by Wiley in The FASEB Journal
- Vol. 20 (7) , 956-958
- https://doi.org/10.1096/fj.05-4763fje
Abstract
Click on the article title to read more.Keywords
Funding Information
- Ludwig-Maximilians-Universität München
This publication has 44 references indexed in Scilit:
- Autologous bone-marrow stem-cell transplantation for myocardial regenerationThe Lancet, 2003
- Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)Circulation, 2002
- Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in HumansCirculation, 2002
- Bone marrow cells regenerate infarcted myocardiumNature, 2001
- Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac functionNature Medicine, 2001
- 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarctionJournal of the American College of Cardiology, 1999
- Programmed Myocyte Cell Death Affects the Viable Myocardium after Infarction in RatsExperimental Cell Research, 1996
- Energy metabolism and contractile function after 15 beats of moderate myocardial ischemia.Circulation Research, 1992
- Ventricular enlargement and remodeling following acute myocardial infarction: Mechanisms and managementThe American Journal of Cardiology, 1991
- Intracoronary thrombolysis in acute myocardial infarction: Duration of ischemia as a major determinant of late results after recanalizationThe American Journal of Cardiology, 1982